ImmunityBio is a clinical-stage biotechnology company that develops cell and immunotherapy products designed to strengthen each patient’s natural immune system, potentially enabling it to outsmart the disease and eliminate cancerous or infected cells. They aim to conquer cancer through the human immune system. ImmunityBio is a publicly traded biopharmaceutical company with headquarters in Southern California, which is growing and collaborative.